🇺🇸 FDA
Patent

US 6245747

Targeted site specific antisense oligodeoxynucleotide delivery method

expired A61KA61K41/0028A61K47/6925

Quick answer

US patent 6245747 (Targeted site specific antisense oligodeoxynucleotide delivery method) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K41/0028, A61K47/6925, A61K9/0009, A61K9/0019